| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |